Teladoc Health (NYSE:TDOC) Trading Up 5.6%

Shares of Teladoc Health, Inc. (NYSE:TDOC) rose 5.6% on Monday . The stock traded as high as $9.12 and last traded at $8.93. Approximately 1,462,871 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 5,531,210 shares. The stock had previously closed at $8.46.

Wall Street Analyst Weigh In

TDOC has been the subject of several recent analyst reports. Piper Sandler dropped their price target on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft decreased their price objective on Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. Barclays decreased their price objective on Teladoc Health from $20.00 to $10.00 and set an “overweight” rating on the stock in a report on Thursday, August 1st. Finally, DA Davidson decreased their price objective on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a report on Thursday, August 1st. Fifteen analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $12.31.

Teladoc Health Stock Up 9.1 %

The company has a fifty day moving average of $7.93 and a two-hundred day moving average of $10.62. The company has a market cap of $1.57 billion, a PE ratio of -6.33 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.36) by $0.08. The company had revenue of $642.44 million for the quarter, compared to the consensus estimate of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. As a group, analysts anticipate that Teladoc Health, Inc. will post -1.18 earnings per share for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, CEO Laizer Kornwasser sold 10,879 shares of the company’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $88,555.06. Following the transaction, the chief executive officer now owns 99,929 shares of the company’s stock, valued at approximately $813,422.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Laizer Kornwasser sold 10,879 shares of the stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $88,555.06. Following the transaction, the chief executive officer now owns 99,929 shares of the company’s stock, valued at approximately $813,422.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Mala Murthy sold 8,750 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $62,650.00. Following the transaction, the chief financial officer now directly owns 85,767 shares in the company, valued at approximately $614,091.72. The disclosure for this sale can be found here. Insiders have sold 57,819 shares of company stock valued at $442,204 in the last quarter. 0.95% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. Point72 Asia Singapore Pte. Ltd. grew its holdings in Teladoc Health by 194.2% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider’s stock worth $67,000 after purchasing an additional 4,549 shares during the last quarter. Granite Bay Wealth Management LLC purchased a new position in Teladoc Health during the 2nd quarter worth $1,111,000. Doheny Asset Management CA acquired a new position in Teladoc Health during the 2nd quarter valued at about $46,000. Clearline Capital LP raised its stake in Teladoc Health by 395.6% in the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock valued at $42,682,000 after buying an additional 3,483,665 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC boosted its holdings in Teladoc Health by 32.9% in the second quarter. Susquehanna Fundamental Investments LLC now owns 265,513 shares of the health services provider’s stock worth $2,597,000 after acquiring an additional 65,767 shares in the last quarter. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.